rhinoviru
exacerb
unlik
parainfl
uenza
exacerb
unlik
infl
uenza
exacerb
unlik
respiratori
syncyti
viru
exacerb
controversi
coronaviru
exacerb
unlik
adenoviru
exacerb
latent
infect
seen
pathogen
signifi
canc
undefi
ned
human
metapneumoviru
exacerb
unlik
atyp
bacteria
chlamydophila
pneumonia
exacerb
commonli
detect
pathogen
signifi
canc
undefi
ned
mycoplasma
pneumonia
unlik
fungi
pneumocysti
jiroveci
undefi
ned
commonli
detect
pathogen
signifi
canc
undefi
ned
k
provost
et
al
acut
exacerb
copd
aecopd
defi
ned
clinic
criteria
outlin
global
initi
chronic
obstruct
lung
diseas
gold
guidelin
includ
acut
increas
one
follow
cardin
symptom
beyond
day
day
variabl
dyspnea
increas
frequenc
sever
cough
increas
volum
chang
charact
sputum
repres
acut
increas
airway
infl
ammat
role
infect
pathogenesi
copd
acut
exacerb
diseas
progress
clinic
research
question
mani
year
pendulum
swung
infect
major
caus
acut
exacerb
copd
british
hypothesi
infect
unrel
epiphomenon
acut
exacerb
back
infect
integr
develop
aecopd
like
import
contributor
copd
progress
upward
aecopd
driven
infecti
stimuli
associ
bacteri
infect
associ
acut
viral
infect
exacerb
dual
bacteri
viral
causat
much
advanc
understand
role
infect
aecopd
due
advanc
clinic
research
tool
allow
research
accur
character
microbi
pathogen
better
understand
hostpathogen
interact
tabl
recent
scientifi
c
accept
infecti
organ
viral
bacteri
signifi
cant
player
aecopd
host
respons
patient
copd
must
also
question
airway
patient
copd
signific
infi
ltration
infl
ammatori
cell
polymorphonuclear
cell
lymphocyt
much
higher
number
alveolar
macrophag
seen
healthi
person
natur
infl
ammatori
infi
ltrate
suggest
support
fi
nding
viral
bacteri
infect
recruit
immun
cell
pertin
innat
adapt
immun
respons
despit
recruit
appropri
effector
immun
cell
mani
patient
advanc
stage
copd
gold
iiiiv
persist
presenc
pathogen
airway
rather
erad
suggest
impair
host
respons
infect
numer
studi
delin
impair
macrophag
phagocytosi
cytokin
secret
impair
humor
immun
respons
infect
impair
tlymphocyt
respons
mechan
impair
respons
innat
adapt
immun
cell
infect
clearli
delin
remain
target
investig
although
tempor
associ
bacteri
presenc
airway
copd
exacerb
fi
rst
recogn
earli
diverg
away
bacteri
causat
aecopd
relat
sever
observ
differ
observ
sputum
bacteri
isol
rate
speci
level
stabl
state
exacerb
studi
immun
respons
studi
bacteri
pathogen
placebo
control
antibiot
trial
show
inconsist
contradictori
result
begin
multipl
investig
began
recogn
effect
bacteri
infect
colon
stabl
copd
direct
associ
aecopd
initi
recogn
bacteri
isol
earli
studi
done
predominantli
sputum
cultur
pathogen
isol
nasopharyng
commens
healthi
adult
rais
issu
specimen
contamin
addit
older
studi
could
differenti
among
strain
pathogen
speci
assum
strain
isol
sputum
time
ident
advanc
diagnost
techniqu
bronchoscopi
protect
specimen
brush
bronchoalveolar
lavag
well
molecular
bacteri
type
allow
identifi
cation
bacteria
streptococcu
pneumonia
haemophilu
infl
uenza
moraxella
catarrhali
pseudomona
aeruginosa
other
potenti
pathogen
concentr
distal
airway
stabl
copd
sever
gold
stage
diseas
associ
identifi
cation
pseudomona
subsequ
studi
went
associ
colon
sever
spirometr
airfl
ow
obstruct
expand
recognit
bacteri
colon
stabl
copd
recogn
preval
bacteria
lower
respiratori
tract
increas
signifi
cantli
aecopd
compar
stabl
copd
sampl
bronchoscopi
scientifi
c
advanc
led
recognit
chang
overal
number
potenti
pathogen
bacteria
airway
period
colon
acut
exacerb
matter
less
acquisit
new
strain
bacteria
acquisit
new
strain
bacteria
h
infl
uenza
catarrhali
pneumonia
p
aeruginosa
associ
greater
likelihood
symptom
exacerb
increas
infl
ammatori
marker
local
system
crp
neutrophil
elastas
develop
specifi
c
host
immun
respons
infect
pathogen
although
author
describ
link
presenc
chlamydia
penumonia
mycoplasma
pneumonia
legionella
infect
aecopd
studi
measur
singl
serolog
titer
rather
serolog
convers
addit
respiratori
pathogen
often
identifi
ed
studi
use
serolog
convers
diagnost
criterion
molecular
detect
identifi
presenc
atyp
bacteri
dna
sputa
aecopd
indic
minor
role
bacteria
exacerb
often
coinfect
typic
bacteri
pathogen
tabl
signifi
cant
role
bacteria
pathogenesi
copd
aecopd
combin
recent
data
improv
microbiolog
detect
techniqu
normal
lung
steril
led
recent
research
focus
understand
microbiom
lung
stabl
copd
exacerb
two
group
recent
publish
data
use
phylochip
microarray
analysi
quantit
pcr
pyrosequenc
variabl
region
rdna
fi
rst
studi
identifi
ed
bacteri
divers
seen
sever
aecopd
requir
intub
eight
patient
note
signifi
cant
bacteri
rich
defi
ned
number
bacteri
taxa
detect
wane
prolong
intub
common
core
bacteri
taxa
repres
classifi
ed
bacteri
famili
identifi
ed
patient
studi
group
includ
member
pseudomonadacea
enterobacteriacea
campylobacteracea
helicobacteracea
famili
among
other
major
bacteria
belong
proteobacteria
phylum
smaller
contribut
firmicut
bacteroidet
second
studi
address
effect
cigarett
smoke
bacteri
divers
compar
healthi
smoker
smoker
copd
nonsmok
investig
demonstr
lung
resid
bacteria
group
domin
phyla
proteobacteria
firmicut
bacteroidet
note
fi
rst
studi
heterogen
bacteri
commun
nonsmok
healthi
smoker
mild
copd
patient
lost
patient
moder
sever
copd
within
patient
geograph
differ
bacteri
heterogen
also
note
suggest
microanatom
differ
bacteri
commun
within
lung
whether
microanatom
spatial
distinct
bacteri
commun
within
lung
overal
airway
bacteri
divers
repres
mechan
diseas
progress
contribut
aecopd
remain
determin
respiratori
tract
viral
infect
long
suspect
capabl
incit
infl
ammat
suffi
cient
gener
acut
exacerb
copd
diagnosi
viral
infect
initi
done
cell
cultur
serolog
method
recent
studi
detect
viral
infect
pcr
either
sputa
bal
nasopharyng
swab
greatest
recoveri
seen
sputa
compar
nasopharyng
swab
commonli
recov
virus
vari
preval
variou
studi
aecopd
use
sensit
pcr
detect
method
infl
uenza
rhinoviru
respiratori
synctial
viru
rsv
parainfl
uenza
major
infect
due
rhinoviru
virus
also
found
stabl
copd
clear
fi
nding
subclin
infect
colon
symptom
activ
infect
preced
day
therefor
presenc
virus
respiratori
sampl
detect
sensit
techniqu
pcr
may
alway
correl
acut
infect
interpret
clinic
context
though
studi
suggest
viral
exacerb
sever
protract
nonvir
exacerb
studi
studi
bacteri
infect
concurr
virallyinduc
aecopd
associ
higher
airway
level
compar
aecopd
viru
detect
presenc
eosinophil
sputa
sampl
recov
aecopd
viral
etiolog
also
differ
infl
ammatori
cell
present
bacteri
noninfecti
aecopd
studi
examin
viral
bacteri
infect
simultan
presenc
dual
infect
associ
increas
clinic
sever
exacerb
copd
recogn
state
chronic
infl
ammat
period
exacerb
mark
acut
increas
infl
ammat
local
system
pathogen
host
factor
determin
outcom
acquisit
bacteri
strain
approxim
half
acquisit
pathogen
bacteria
lead
exacerb
pathogen
virul
like
also
play
role
determin
acquisit
lead
acut
exacerb
strain
nontyp
h
infl
uenza
nthi
associ
exacerb
effect
adher
airway
epithelium
result
increas
secret
vitro
mous
model
compar
strain
associ
colon
demonstr
higher
level
neutrophil
recruit
airway
also
signifi
cant
differ
host
respons
differ
pathogen
patient
copd
abl
erad
moraxella
catarrhali
streptococcu
pneumonia
airway
quit
well
follow
exacerb
like
relat
effect
immun
respons
howev
though
antibodi
respons
develop
nthi
pseudomona
follow
exacerb
effect
clearanc
often
seen
pathogen
innat
immun
respons
immedi
respons
immun
defens
invad
pathogen
anatom
function
barrier
mucociliari
clearanc
epitheli
tight
junction
well
cellular
immun
recognit
invad
pathogen
via
germlin
encod
pathogen
recognit
receptor
tlr
nod
solubl
mediat
slpi
lysozym
collectin
initi
innat
respons
multifacet
includ
epitheli
cell
upper
lower
airway
airway
resid
macrophag
dendrit
cell
recruit
polymorphonuclear
cell
multipl
author
demonstr
associ
increas
infl
ammatori
cytokin
present
airway
patient
copd
bacteri
infect
colon
lower
airway
domin
cytokin
involv
also
seen
aecopd
due
infect
suggest
common
innat
immun
respons
time
exacerb
sourc
cytokin
may
either
airway
epithelium
adhes
invas
bacteri
viral
pathogen
alveolar
macrophag
recognit
pathogen
associ
molecular
pattern
pamp
activ
toll
like
receptor
tlr
alveolar
macrophag
also
less
abl
phagocytos
bacteria
patient
copd
less
robust
respons
bacteri
protein
specifi
calli
lo
nthi
less
abl
clear
apoptot
cell
airway
diseas
cigarett
smoke
exposur
contribut
rel
hyporespons
alveolar
macrophag
smoker
ceas
smoke
better
phagocyt
abil
continu
smoke
reduc
rel
healthi
control
ongo
presenc
apoptot
cell
airway
may
function
sourc
endogen
ligand
inappropri
selfdirect
immun
respons
normal
mucociliari
clearanc
mcc
maintain
steril
tracheobronchi
tree
effect
trap
clear
inhal
microaspir
particl
includ
infecti
pathogen
smoke
disrupt
mcc
induc
structur
abnorm
ciliari
apparatu
investig
shown
impair
mcc
univers
though
variabl
moderatetoheavi
smoker
develop
chronic
bronchiti
airway
obstruct
smoker
associ
deterior
mcc
infi
ltrate
neutrophil
like
contribut
mcc
impair
probabl
mediat
increas
mucu
product
mediat
proteolyt
cleavag
increas
egf
receptor
egfr
bind
reduc
ciliari
beat
reduc
viscoelast
properti
mucu
tobacco
smoke
also
effect
airway
level
solubl
iga
literatur
demonstr
confl
ict
result
though
trial
quit
heterogen
support
issu
import
secret
airway
immun
recent
trial
support
geograph
chang
structur
integr
lung
demonstr
local
area
iga
defi
cienci
associ
alter
epitheli
cell
integr
reduc
pigr
express
polymer
igg
receptor
requir
trancytosi
structur
compon
iga
molecul
basolater
apic
surfac
epitheli
cell
reduct
express
iga
transport
system
support
fi
nding
reduc
total
iga
bal
patient
copd
contrast
system
iga
respons
elicit
bronchial
mucosa
seem
preserv
copd
demonstr
copd
patient
chlamydia
pneumonia
infect
increas
number
polypeptid
antimicrobi
activ
identifi
ed
airway
surfac
fl
uid
may
play
import
role
host
defens
respiratori
tract
one
major
group
peptid
cation
polypeptid
includ
lysozym
lytic
mani
bacteri
membran
lactoferrin
exclud
iron
bacteri
metabol
defensin
releas
leukocyt
respiratori
epitheli
cell
cathelicidin
famili
protein
found
human
present
specifi
c
granul
neutrophil
airway
epitheli
cell
defi
cienci
salivari
lysozym
sputum
secretori
leukocyt
proteas
inhibitor
slpi
relat
frequent
exacerb
patient
normal
baselin
slpi
level
level
drop
signifi
cantli
time
infect
exacerb
return
normal
resolut
exacerb
lower
level
lysozym
lactoferrin
note
colon
infect
exacerb
nthi
moraxella
catarrhali
compar
preacquisit
level
contrast
level
shown
increas
presenc
airway
bacteria
state
colon
well
infect
greater
increas
infect
exacerb
compar
colon
diverg
respons
airway
antimicrobi
peptid
infect
exacerb
underscor
fundament
import
hostpathogen
interact
lower
level
may
relat
consumpt
face
infect
mechan
bacteri
evas
immun
clearanc
role
tobacco
smoke
specifi
calli
antimicrobi
peptid
well
studi
though
murin
model
suggest
least
regard
slpi
presenc
tobacco
smoke
deleteri
proteas
inhibitori
activ
anoth
import
group
antimicrobi
polypeptid
collectin
surfact
proteina
spa
surfact
proteind
spd
collectin
broad
spectrum
antimicrobi
activ
also
promot
phagocytosi
particul
alveolar
macrophag
concentr
spa
spd
decreas
smoker
decreas
associ
emphysema
fi
nding
note
human
anim
model
mannos
bind
lectin
mbl
defi
cienci
strongli
implic
infect
copd
exacerb
odd
ratio
infect
exacerb
compar
normal
mbl
level
though
consider
progress
made
understand
basic
biolog
polypeptid
role
respons
respiratori
infect
pathogenesi
copd
still
poorli
understood
pattern
recognit
receptor
transmembran
tolllik
receptor
tlr
cytosol
nucleotidebind
oligomer
domain
nod
like
receptor
nlr
rigilik
receptor
predomin
germlin
encod
receptor
recogn
conserv
sequenc
present
mutipl
infecti
organ
pathogen
associ
molecular
pattern
pamp
nonspecifi
c
recognit
provid
immedi
immun
respons
innat
without
initi
requir
effector
memori
respons
tabl
recent
evid
suggest
tlr
signal
restrict
microorgan
particl
tlr
recogn
wide
varieti
signal
heat
shock
protein
hyaluronan
fragment
oxid
stress
neutrophil
nonclass
activ
damageassoci
molecular
pattern
damp
activ
may
explain
proinfl
ammatori
state
seen
cigarett
smoke
healthi
control
recent
data
defi
ne
direct
effect
cigarett
smoke
induc
mmp
secret
epitheli
cell
mediat
activ
independ
lp
present
extract
neutral
addit
antioxid
suggest
oxid
stress
induc
activ
classic
patternrecognit
role
tolllik
receptor
pamp
recognit
affect
tobacco
smoke
well
develop
copd
antigen
present
cell
dendrit
cell
alveolar
macrophag
well
airway
epithelium
decreas
level
airway
epitheli
cell
well
alveolar
macrophag
demonstr
presenc
cigarett
smoke
well
patient
establish
copd
presum
past
lower
level
tlr
contribut
impair
immun
respons
pathogen
bacteria
face
newer
data
demonstr
activ
reactiv
oxygen
speci
present
cigarett
smoke
may
yet
repres
downregul
attempt
curb
detriment
infl
ammatori
process
though
yet
investig
presenc
solubl
form
tlr
well
emerg
fi
eld
studi
level
protein
factor
lower
level
cell
surfac
express
yet
defi
ned
natur
killer
cell
classifi
ed
lymphocyt
base
morpholog
lack
antigen
specifi
c
receptor
put
respons
within
realm
innat
immun
respons
cell
found
within
airway
well
lung
parenchyma
act
cytolyt
effector
lymphocyt
induc
cell
death
infect
structur
cell
lung
secret
perforin
granzym
b
increas
number
nk
cell
nkt
cell
note
induc
sputum
patient
copd
compar
healthi
smoker
normal
control
cell
patient
copd
express
greater
cytolyt
activ
invers
correl
dendrit
cell
canon
antigen
present
cell
link
innat
adapt
immun
respons
dendrit
cell
act
local
upon
antigen
recognit
cytokin
secret
lymphoid
follicl
migrat
primari
site
dendrit
cell
function
primarili
promot
differenti
helper
lymphocyt
well
cytotox
tobacco
smoke
associ
expans
dendrit
cell
popul
lung
langerhanslik
dendrit
cell
subepitheli
bal
myeloid
dendrit
cell
select
recruit
airway
demonstr
increas
express
costimulatori
marker
smoker
compar
nonsmok
patient
copd
dendrit
cell
subset
myeloid
plasmacytoid
demonstr
increas
costimulatori
molecul
express
correl
copd
sever
explain
smoke
alon
lung
dendrit
cell
coordin
coloc
lymphocyt
induc
respons
increas
number
advanc
matur
state
myeloid
plasmacytoid
dendrit
cell
airway
patient
progress
gold
stage
copd
suggest
enhanc
antigen
present
capac
develop
sever
diseas
whether
develop
respons
bacteri
colon
frequent
antigen
recognit
lead
self
antigen
present
antielastin
antiendothelin
progress
autoimmun
whether
matur
dendrit
cell
engend
state
toler
via
interact
lymphocyt
defi
ned
innat
adapt
immun
respons
alter
copd
smoke
antigen
specifi
c
effector
memori
respons
cell
mediat
humor
arm
adapt
immun
respons
requir
effect
clear
establish
infect
effector
memori
respons
respond
slowli
innat
immun
respons
highli
specifi
c
pathogen
involv
airway
patient
copd
note
retain
signifi
cant
number
infl
ammatori
cell
innat
adapt
immun
respons
adapt
immun
respons
effector
lymphocyt
lineag
document
airway
subepitheli
space
predomin
presenc
number
cytolyt
activ
cell
increas
substanti
patient
copd
progress
gold
stage
diseas
elev
level
interferon
gamma
found
bal
intracellular
stain
lymphocyt
suggest
effector
phenotyp
lymphocyt
found
airway
patient
copd
two
subtyp
identifi
ed
cell
lung
lymphocyt
lineag
increas
sever
copd
emphysema
secret
interferon
gamma
control
smoker
cell
newli
recogn
lymphocyt
subset
regul
tissu
infl
ammat
produc
cell
regul
immun
extracellular
pathogen
also
associ
autoimmun
act
airway
epitheli
cell
induc
antimicrobi
peptid
gcsf
gmcsf
chemokin
secret
recent
data
may
support
geograph
restrict
role
two
form
local
infl
ammatori
hematopoiet
cell
subepithelium
small
airway
local
lymphoid
follicl
epitheli
cell
b
cell
shown
present
increas
number
larg
small
airway
patient
copd
organ
lymphoid
follicl
around
airway
parenchyma
patient
copd
advanc
gold
stage
diseas
follicl
contain
memori
b
cell
cell
dendrit
cell
follicular
dendrit
cell
allow
b
cell
prime
clonal
expans
b
cell
balt
oligoclon
suggest
antigen
specifi
c
immun
antigen
involv
respons
identifi
ed
lead
candid
includ
microbi
antigen
cigarett
smokederiv
antigen
damageassoci
antigen
apoptosi
extracellular
matrix
degrad
autoantigen
despit
recruit
appropri
effector
cell
popul
patient
advanc
copd
abl
effect
clear
bacteri
infect
bacteri
colon
result
whether
breakdown
sole
level
innat
immun
respons
interfac
innat
adapt
immun
respons
due
derang
adapt
immun
respons
alon
clear
like
diseas
progress
progress
dysregul
immun
respons
invad
pathogen
downward
spiral
infl
ammat
infect
alter
immun
respons
infl
ammat
tissu
injuri
amplifi
ed
period
aecopd
